The Center supports regulatory science research and hosts workshops, symposia, and other community-building and educational opportunities for the regulatory science community. Whether you are interested in regulatory science as a student, academic researcher, industry professional, or government professional, we welcome you to our community of enthusiasts.
Check out our Events for upcoming programming, stay updated on the latest news from the Center, or find out about local regulatory science opportunities, by signing up for our bimonthly mailing list. A few of our opportunities are highlighted below.
Drug-drug interaction detection in real-world claims data and healthcare records
For this position, the Fellow will work with faculty at Harvard in the Department of Biomedical Informatics https://dbmi.hms.harvard.edu. The fellow will be based in the Avillach Lab, an interdisciplinary research group focused on the development of cutting edge techniques for the integration of multiple heterogeneous biological and clinical cohorts with the overarching goal of supporting individualized data-driven healthcare.
Research activities include, but are not limited to:
- Extract and analyze information from a nationwide claims database including 67 million subjects
- Extract and analyze information from healthcare records in an academic pediatric hospital including 1.8 million patients
- Develop and test methods to detect adverse drug reactions from billing codes, drug prescriptions and lab value results
- Disseminate findings through national and international conferences and in peer-reviewed scientific publications
- PhD in computer science, engineering or a related field
- Expertise in SQL query language
- Expertise in R or Python programing languages
The FDA and Prescription Drugs: Current Controversies in Context
This free, self-paced, six-session online course will cover pharmaceutical product development, approval, marketing, and costs, as well as an overview of FDA and the major issues affecting regulatory approval and evidence-based use of prescription drugs. For more information on the course material, watch this introductory video here. The course is run by the Program on Regulation, Therapeutics, and Law (PORTAL), a CRS partner program, in conjunction with HarvardX/edX, and is currently ongoing.